Biomakers
Boston, MA · Biotechnology · 77 employees
Biomakers is a precision medicine and oncology intelligence company transforming clinical and genomic information into actionable insights for therapeutic and diagnostic development. Headquartered in San Francisco, with clinical laboratories in Mexico, Brazil, and Argentina, Biomakers operates across Latin America and the United States, enabling global partners to access diverse, high-quality data
Funding history
- Funding Round — $5.9M — Apr 2026
- Funding Round — $8.0M — Jan 2026
- Series seed — $2.4M — Feb 2025
- Series seed — $2.4M — Feb 2024
Recent signals
- Apr 29, 2026: Raised $5.9M
- Jan 21, 2026: BIOMAKERS Appoints Ezequiel Renzulli as Chief Operating Officer
- Jan 20, 2026: Raised $8.0M
- Feb 11, 2025: Raised $2.4M in Series seed
- Feb 12, 2024: Raised $2.4M in Series seed
See plans & pricing → Track Biomakers’s funding, hiring, and signals — with verified contacts — on Fundz.